OpenVSafe by OpenVAERS
Search V-safe

AGU-62297-76637

2 vaccinations 2 coded responses 4 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
804 / CO
Registered
2021-03-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-23
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-25
    Registered in v-safe
  3. 2021-03-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Fatigue or tiredness
    Free text: Runny nose, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Nasal congestion, Respiratory tract congestion — Feeling: Fair
    Free text: Congestion, stuffy nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-08
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  6. 2021-04-13
    Dose 2 — Pfizer-BioNTech
  7. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-23Pfizer-BioNTech
22021-04-13Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-25

Systemic reaction (other): Runny nose, sore throat

2021-03-26

Systemic reaction (other): Congestion, stuffy nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SRONasal congestion ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release